New to the Huntington's Disease Lighthouse?
 Welcome to the HDlighthouse!
 Getting started.
 
Welcome to the HDL

Huntington's Harbor Lighthouse.
This is the Huntington Harbor Lighthouse which is located north of Long Island where Dr. George Huntington observed and wrote about Huntington's Disease patients. It was chosen as a symbol of this Web site which will continue to offer a beacon of hope to families coping with Huntington's Disease until all of our ships are home safe in harbor.
© Kraig Anderson. Used by permission.

Welcome
The HDLighthouse mission is to present and explain the latest research findings so that HD families can become proactive in their care, have hope for the future, and make good decisions in the present.

Welcome to the new Huntington's Disease Lighthouse site
Beginners Start Here
Disclaimer & Privacy Policy
Meet the Huntington's disease web team
Navigation Explained
All Files On This Site.
Huntington's Disease Updates
3 Jun 2009
Medivation to begin a Phase III trial of Dimebon
Medivation is sponsoring a randomized, double-Blind, placebo-controlled, Phase III trial of Dimebon in patients with mild to moderate Huntington’s Disease
 
24 Apr 2009
Acetylation of the HD protein
MSG-MIND researchers discover a new therapeutic target: increased acetylation enhances clearance of the HD ptotein from the nucleus.
 
24 Apr 2009
An ampakine upregulates BDNF
An ampakine, a modulator of glutamate receptors, reduced memory and learning problems in HD mice.
 
23 Apr 2009
Minocycline Phase II clinical trial results are disappointing
 
23 Apr 2009
CERE-120 (AAV-Neurturin) is neuroprotective in HD mouse model
Neurturin. a neurotrophic factor, protected striatal and cortical neurons in an HD mouse model.
 
23 Apr 2009
Disappointing results from a Phase II trial of CERE-120 for PD patients
Neurturin, a neurotrophic factor, failed to yield meaningful improvement in PD patients.
 
8 Apr 2009
Amarin files new drug application for AMR 101 in Europe
Ethyl-EPA remains in the drug development pipeline.
 
8 Apr 2009
Toxic HD protein fragments
Research continues to support the toxic fragment hypothesis.
 
27 Feb 2009
Warning about Reglan
Metoclopramide (Reglan) poses risks to those with HD and PD.
 
3 Feb 2009
The ACR-16 trial is enrolling participants
An interview with lead investigator Dr. Karl Kieburtz.
 

All Updates for Home
Your Proactive Battle With HDbluedown.gif
HDL Triad HDL Triad
You can fight back.
Your triad is exercise, diet and spirit
2blue.gif
HD Drug Pipeline HD Drug Pipeline
See the progress that HD treatments are making as they move from the lab to you.
2blue.gif
Image of pills Potential Agents
Treatment Now! Agents with potential benefits
2blue.gif
Huntington Project Logo Huntington Project
Find out what is happing in HD trials and treatments at the Huntington Project.
Creatine Now in Clinical Trials
Latest news on Creatine...
2blue.gif
Yum! Blueberries Blueberries Help Brain
Anthocyanin Promotes Neurogenesis
HD Drug Works
HD Drug Works logo Connecting HD people to HD research.
Huntington's Disease Drug Works
Community
Forum Launch HDAC Message Board & Chat
Calandar JPG Huntington's Disease Event Calendar
Coming Events, Notices
Phil Hart Photo

Managing Huntington's Disease: Visit the Navigating Life section where Contributing Author Phil Hardt's provides several tips on handling problems caused by HD.
Make better decisions now!
14 changes that could signal concern.
Eliminating suicide
HD Care Standards - The problem and the challenges.
Step by Step Social Security

Disclaimer & Privacy Policy | Welcome | Site Feedback Marsha@HDLighthouse.org